$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Verona Pharma plc (NASDAQ: VRNA)

Core Insights - Monteverde & Associates PC is investigating Verona Pharma plc regarding its sale to Merck Sharp & Dohme LLC for $107.00 per American Depository Share, questioning the fairness of the deal [1] Group 1: Company Overview - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has recovered millions for shareholders [1] - The firm is located in the Empire State Building, New York City, and specializes in class action securities litigation [2] Group 2: Legal Services - The firm offers free consultations for shareholders concerned about the sale of Verona Pharma plc [1][3] - Contact information for Juan Monteverde, Esq. is provided for shareholders seeking additional information [3]